Prevention and treatment scheme optimization system and method for chronic diseases in field of traditional Chinese medicine

Abstract

The invention provides a prevention and treatment scheme optimization system and method for chronic diseases in the field of traditional Chinese medicine, and the system comprises an HTA evaluation module which is used for screening a suitable prevention and treatment technology group based on a clinical effect index, an economic index and a patient experience index, wherein the suitable prevention and treatment technology group comprises at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine; the implementation evaluation module is used for constructing an i-PARIHS framework in the current medical scene based on the knowledge, background and promotion factors of the current medical scene, and obtaining the implementation effect of the prevention and treatment technology in the suitable prevention and treatment technology group in the i-PARIHS framework; and the prevention and control scheme optimization module is used for optimizing the prevention and control scheme based on the implementation effect of the prevention and control technology and can improve the efficiency of the chronic disease prevention and control scheme.

Description

Technical Field

[0001] The present application relates to the field of health management, and in particular to a system and method for optimizing prevention and treatment plans for chronic diseases in the field of traditional Chinese medicine. Background Art

[0002] In the field of health management technology, as people pay more and more attention to health, the demand for efficient and accurate health management technology is growing. In particular, as the incidence of chronic diseases continues to rise, chronic disease prevention and treatment has become a top priority in the field of health management.

[0003] Chronic disease prevention and treatment refers to the process of taking a series of comprehensive measures to prevent the occurrence of chronic diseases, control their development, reduce their harm, and improve the quality of life of patients. At present, the prevention and treatment technology for chronic diseases mainly adopts the prevention and treatment methods of traditional Chinese medicine. The prevention and treatment technology of chronic diseases in the field of traditional Chinese medicine includes traditional Chinese medicine conditioning, acupuncture and massage, cupping and scraping, diet conditioning, etc. After the traditional Chinese medicine doctor diagnoses the pulse of the chronic disease patient, he will issue a chronic disease prevention and treatment plan. However, this prevention and treatment method has many disadvantages:

[0004] 1. Insufficient dynamic updates: In the prevention and treatment of chronic diseases in the field of traditional Chinese medicine, the current health portrait and intervention system has obvious timeliness shortcomings. It is difficult to capture and accurately reflect the dynamic changes in the patient's health status in real time, and thus it is impossible to adjust the traditional Chinese medicine prevention and treatment strategy in time according to the real-time fluctuations of the patient's condition, such as the adjustment of Chinese medicine prescriptions, the frequency of acupuncture and massage, and the change of acupoints. This makes it impossible for traditional Chinese medicine prevention and treatment to closely meet the patient's current actual health needs, miss the best time for intervention, and affect the effectiveness of traditional Chinese medicine in chronic disease management.

[0005] 2. Lack of personalization: Traditional Chinese medicine health intervention programs generally fail to fully consider the unique behavioral patterns and diverse actual needs of patients, and lack precise targeting. Traditional Chinese medicine emphasizes syndrome differentiation and personalized treatment based on individual differences, but in actual operation, existing programs are difficult to deeply customize according to the specific circumstances of each patient. For example, in terms of traditional Chinese medicine conditioning, the patient's living habits (such as dietary preferences, work and rest patterns) are not fully combined to optimize the medication plan; in acupuncture and massage treatment, the patient's individual tolerance to pain and physical reaction are not fully considered to adjust the strength of the manipulation and the selection of acupoints, resulting in limited prevention and treatment effects, and the inability to fully demonstrate the advantages of personalized treatment of traditional Chinese medicine.

[0006] 3. Weak prediction and prevention capabilities: The existing TCM prevention and treatment system is weak in predicting and preventing health risks of chronic diseases. Although TCM has the concept of "preventing disease before it occurs", in actual operation, due to the lack of advanced technical means and effective data integration and analysis capabilities, it is difficult to keenly detect subtle signs of potential health risks of patients in advance, and it is impossible to initiate targeted TCM prevention measures in time, such as TCM conditioning or health guidance in advance based on physical constitution identification. This greatly reduces the initiative and foresight of TCM in disease prevention, and patients cannot receive timely and effective early intervention of TCM when facing the threat of chronic diseases.

[0007] 4. Low intelligent decision-making and response capabilities: In the application of IoT platforms in the field of traditional Chinese medicine, there are significant deficiencies in equipment collaboration, resulting in low intelligent decision-making and response capabilities. For example, there is a lack of efficient coordination mechanisms between remote TCM diagnostic equipment and TCM distribution systems, acupuncture and massage appointment platforms, etc., and information transmission is not smooth. This has caused a delay in the start of TCM intervention measures and has been unable to keep up with the pace of changes in patients' health status. At the same time, inefficient equipment collaboration has also affected the optimization of TCM intervention effects. For example, it is impossible to adjust the temperature and time of smart moxibustion equipment in a timely manner according to patients' real-time health data, making it difficult to fully tap the potential of IoT technology in TCM health management.

[0008] 5. Insufficient closed-loop optimization: There are serious limitations in the interaction between users and the system in the TCM prevention and treatment system, and there is a lack of effective feedback mechanisms to promote the continuous optimization of health management programs. It is difficult for the system to comprehensively collect patient feedback after receiving TCM treatment (such as physical reactions after taking TCM, symptom improvement after acupuncture and massage) and actual health data changes, and it is impossible to accurately adjust and improve TCM intervention programs based on this information. This makes the TCM health management program in a relatively static state, unable to adapt to the dynamically changing health conditions and needs of patients, and it is difficult to achieve a gradual improvement in the effectiveness of TCM in the prevention and treatment of chronic diseases. Summary of the invention

[0009] The present application provides a system and method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine. It uses HTA to comprehensively evaluate prevention and treatment technologies, and based on the i-PARIHS framework, it implements the evaluation of prevention and treatment technologies for chronic diseases in the field of traditional Chinese medicine in different medical scenarios, optimizes the prevention and treatment plans for chronic diseases in the field of traditional Chinese medicine to improve prevention and treatment efficiency and quality.

[0010] To achieve the above objectives, in the first aspect, this solution provides a system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine, including:

[0011] HTA evaluation module, used to screen appropriate prevention and treatment technology groups based on clinical effect indicators, economic indicators and patient experience indicators, where the appropriate prevention and treatment technology group includes at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine;

[0012] The implementation evaluation module is used to build the i-PARIHS framework based on the knowledge, background and facilitating factors of the current medical scenario, and obtain the implementation effect of the prevention and control technologies in the appropriate prevention and control technology group in the i-PARIHS framework;

[0013] The control scheme optimization module is used to optimize the control scheme based on the implementation effect of the control technology.

[0014] Secondly, this program provides a method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine, including:

[0015] Based on clinical effect indicators, economic indicators and patient experience indicators, the appropriate prevention and treatment technology group is screened, where the appropriate prevention and treatment technology group includes at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine;

[0016] Build the i-PARIHS framework based on the knowledge, background and facilitating factors of the current medical scenario, and obtain the implementation effect of the prevention and control technologies in the appropriate prevention and control technology group in the i-PARIHS framework;

[0017] Optimize prevention and control plans based on the implementation effects of prevention and control technologies.

[0018] Different from the prior art, the main contributions and innovations of the present invention are as follows:

[0019] 1. Comprehensive evaluation and multi-dimensional analysis: This program uses the HTA evaluation module to comprehensively consider clinical effects (such as blood sugar control and other indicators), economic efficiency (cost-effectiveness ratio, etc.), patient experience (satisfaction, quality of life) and social acceptance-related factors. Through multi-dimensional (clinical effect, economic efficiency, patient experience, etc.) comprehensive evaluation, it provides comprehensive and scientific technical evaluation results to ensure the maximization of the multi-faceted effects of the technology.

[0020] 2. Combination of implementation optimization and background analysis: Based on the implementation evaluation module of the i-PARIHS framework, consider knowledge (such as technology maturity), background (social culture, policies and regulations, etc.) and promoting factors (support from medical institutions, etc.), and evaluate the effect of technology implementation in combination with local actual conditions to ensure that the technology adapts to different environments, make up for the lack of consideration of background factors in existing technologies, and improve the success rate of technology implementation. Combined with the implementation background and environmental factors, accurately identify obstacles and promoting factors to ensure the smooth implementation of the technology and avoid implementation difficulties caused by the incompatibility of the background environment.

[0021] 3. Real-time feedback and dynamic optimization: The feedback evaluation module collects patient health data and doctor feedback, such as symptom changes, doctor treatment observations, etc., and calculates feedback evaluation through weighted functions. According to the feedback, timely adjust the implementation effect of prevention and treatment technology and dynamically optimize the plan. Through real-time data feedback, the implementation plan can be dynamically adjusted to make the treatment more personalized, improve the treatment effect and patient compliance.

[0022] 4. Comprehensive optimization of multiple technologies: The prevention and treatment program optimization module builds an optimization model that integrates the implementation effects of multiple technologies, resource constraints, and patient needs. For example, in the prevention and treatment of chronic diseases, the resource consumption and patient coverage of different technologies (traditional Chinese medicine, acupuncture, etc.) are weighed, and resources are allocated reasonably. By adjusting the technology combination, the overall optimal configuration is achieved, the problem of the lack of comprehensive optimization of existing technologies is solved, and the overall benefits of the prevention and treatment program are improved. Comprehensively optimize the implementation paths of multiple technologies, achieve the best configuration under the constraints of resources and patient needs, maximize the treatment effect, and allocate resources reasonably.

[0023] 5. Scalability and adaptability: It can be flexibly applied to different chronic diseases, various traditional Chinese medicine prevention and treatment technologies and different medical scenarios. Whether it is a grassroots health center or an urban hospital, it can be evaluated and optimized according to the actual situation, adapt to diverse needs, and effectively solve the problem of poor flexibility of existing technologies. It has wide application potential. It is highly scalable and suitable for different diseases and technical fields, and has wide application potential.

[0024] Details of one or more embodiments of the present application are set forth in the following drawings and description to make other features, objects, and advantages of the present application more readily apparent. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:

[0026] Figure 1 This is a schematic diagram of the framework of the optimization system for the prevention and treatment of chronic diseases in the field of traditional Chinese medicine provided by this solution.

[0027] Figure 2 This is another framework diagram of the optimization system for the prevention and treatment of chronic diseases in the field of traditional Chinese medicine provided by this solution.

[0028] Figure 3 This is a flow chart of the optimization method for the prevention and treatment of chronic diseases in the field of traditional Chinese medicine provided by this program.

[0029] Figure 4 This is another flow chart of the method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine provided by this solution. DETAILED DESCRIPTION

[0030] Exemplary embodiments will be described in detail herein, examples of which are shown in the accompanying drawings. When the following description refers to the drawings, the same numbers in different drawings represent the same or similar elements unless otherwise indicated. The implementations described in the following exemplary embodiments do not represent all implementations consistent with one or more embodiments of this specification. Instead, they are merely examples of devices and methods consistent with some aspects of one or more embodiments of this specification as detailed in the appended claims.

[0031] It should be noted that: in other embodiments, the steps of the corresponding method are not necessarily performed in the order shown and described in this specification. In some other embodiments, the steps included in the method may be more or less than those described in this specification. In addition, a single step described in this specification may be decomposed into multiple steps for description in other embodiments; and multiple steps described in this specification may be combined into a single step for description in other embodiments.

[0032] Embodiment 1

[0033] The embodiment of the present application provides a prevention and treatment scheme optimization system for chronic diseases in the field of traditional Chinese medicine, which can be applied to different medical scenarios, and is used to evaluate the prevention and treatment technologies of specific chronic diseases in the field of traditional Chinese medicine in specific medical scenarios and select the most suitable technology, and can design personalized prevention and treatment schemes based on the most suitable technology. The medical scenarios mentioned in this scheme include but are not limited to grassroots health centers, urban hospitals, government departments, telemedicine platforms, etc., and different medical scenarios have different evaluation strategies for prevention and treatment technologies. For example, the evaluation strategy of grassroots health centers requires that the current prevention and treatment technologies meet the technical feasibility of low-resource environments, the evaluation strategy of urban hospitals requires that the current prevention and treatment technologies can improve patient compliance, the evaluation strategy of government departments requires that the current prevention and treatment technologies comply with the hierarchical prevention and control strategy, and the evaluation strategy of telemedicine platforms requires that the current prevention and treatment technologies support the management of chronic diseases in remote areas. The prevention and treatment scheme optimization system for chronic diseases in the field of traditional Chinese medicine provided by this scheme is aimed at different medical scenarios, and the multi-dimensional technical attributes of the technology are comprehensively evaluated to select the most suitable technology, and the scenario parameters and technical parameters of the medical scenario can be combined to calculate the fitness of the most suitable technology, thereby providing personalized prevention and treatment schemes, and realizing the comprehensive evaluation and implementation optimization evaluation of specific evaluation strategies.

[0034] like Figure 1 As shown, the optimization system for the prevention and treatment of chronic diseases in the field of traditional Chinese medicine includes:

[0035] HTA evaluation module, used to screen appropriate prevention and treatment technology groups based on clinical effect indicators, economic indicators and patient experience indicators, where the appropriate prevention and treatment technology group includes at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine;

[0036] The implementation evaluation module is used to build the i-PARIHS framework based on the knowledge, background and facilitating factors of the current medical scenario, and obtain the implementation effect of the prevention and control technologies in the appropriate prevention and control technology group in the i-PARIHS framework;

[0037] The control scheme optimization module is used to optimize the control scheme based on the implementation effect of the control technology.

[0038] The optimization system for the prevention and treatment of chronic diseases in the field of traditional Chinese medicine in this program aims to conduct a comprehensive evaluation of prevention and treatment technologies through HTA technology, so as to screen out prevention and treatment technologies that meet scientific and economic requirements, and then promote the implementation and popularization of the selected technologies in medical scenarios through the i-PARIHS framework.

[0039] Specifically, in the HTA evaluation module, clinical effect indicators refer to indicators that reflect the therapeutic effects of current prevention and treatment technologies, including but not limited to efficacy indicators, treatment success rate, etc.; for example, in the process of treating diabetes with traditional Chinese medicine, blood sugar control level is an important efficacy indicator, which may include fasting blood sugar value, postprandial blood sugar value, glycosylated hemoglobin (HbA1c) level, etc. By regularly testing the changes in these blood sugar indicators of patients, the effect of prevention and treatment technology on blood sugar control can be intuitively reflected. For another example, taking the treatment of chronic hepatitis B with traditional Chinese medicine as an example, the treatment success rate can be defined as the proportion of patients whose hepatitis B virus DNA turns negative and whose liver function returns to normal after a certain course of treatment (such as one year).

[0040] Economic indicators refer to indicators that reflect the cost-effectiveness of current prevention and treatment technologies, including but not limited to cost-effectiveness ratio, cost-benefit analysis, etc. For example, taking the treatment of chronic gastritis with traditional Chinese medicine as an example, assuming that the prevention and treatment technology of traditional Chinese medicine conditioning combined with acupoint massage is adopted, the direct medical cost of a course of treatment (three months) is 2,000 yuan, and the transportation and work loss expenses incurred by the patient for medical treatment total 500 yuan, and the total treatment cost is 2,500 yuan. After treatment, the patient's symptoms such as stomach pain, bloating, and acid reflux were significantly relieved, and the quality of life was significantly improved. In addition, the patient avoided subsequent high medical expenses due to the reduction of recurrence of the disease. After evaluation, the benefits obtained were equivalent to 5,000 yuan. The cost-effectiveness ratio of this prevention and treatment technology is 2500:5000=1:2, indicating that 2 yuan of benefits can be obtained for every 1 yuan of cost invested.

[0041] Patient experience indicators refer to indicators that reflect the patient experience of current prevention and treatment technologies, including but not limited to satisfaction, quality of life, etc. Satisfaction can be collected through questionnaires, patient interviews, etc., while quality of life can be assessed through quality of life assessment tools such as the Short Form Health Survey (SF-36), which covers eight aspects, including physiological function, physiological role, bodily pain, overall health, vitality, social function, emotional role, and mental health.

[0042] In an embodiment of the present scheme, for each prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine, the clinical effect indicators, economic indicators, and patient experience indicators of the current prevention and treatment technology are obtained and the weighted sum is used to obtain the comprehensive evaluation score of the current prevention and treatment technology, and the prevention and treatment technologies with a comprehensive evaluation score greater than the set threshold are screened to form an appropriate prevention and treatment technology group.

[0043] The details are as follows: i , set the evaluation index set to {C i ,E i ,S i}, where: C i : Clinical effect index; E i : Economic index; S i : Patient experience index; obtain the comprehensive evaluation score S of each prevention and treatment technology by weighted summation HTA (T i ): S HTA (T i )=w C ·C i +w E ·E i +w S ·S i , where w C ,w E ,w S is the weight of the corresponding indicator, and the respective weights are determined through expert discussion and meet w C +w E +w S =1; and screen out the control technologies with comprehensive evaluation scores greater than the set threshold to form an appropriate control technology group T selected ={T i |S HTA (T i )≥T threshold}, where T threshold : Set the threshold.

[0044] It should be noted that the HTA evaluation module provided by this program uses a multi-dimensional evaluation index system to conduct a comprehensive, systematic and scientific evaluation of various types of traditional Chinese medicine prevention and treatment technologies, so as to accurately screen out appropriate prevention and treatment technology groups that have good clinical effects, comply with economic principles, and can bring high-quality experience to patients.

[0045] After using the HTA assessment module to obtain the appropriate prevention and treatment technology group, this plan uses the implementation assessment module to analyze the implementation background, and then evaluates the implementation effect of the prevention and treatment technology in different medical scenarios.

[0046] Specifically, knowledge refers to the feasibility of implementing the prevention and treatment technology in the current medical scenario. For example, the implementation of important processing technology in the current medical scenario has high feasibility, while the feasibility of implementing transdermal patches of traditional Chinese medicine may be poor. The feasibility of implementing each prevention and treatment technology needs to be evaluated according to different medical scenarios. Background refers to the environmental factors for the implementation of the prevention and treatment technology in the current medical scenario, including the social and cultural environment, the prevention and treatment strategy environment, and the level of economic development. For example, in Guangdong, due to the hot and humid climate, people have a long history of using traditional Chinese medicine health care methods such as diet therapy and herbal tea, and have a deep cultural identity, which makes it easier to promote and implement traditional Chinese medicine in the prevention and treatment of chronic diseases such as damp-heat constitution-related diseases (such as eczema, gastrointestinal damp-heat, etc.); for another example, in economically underdeveloped areas, resources are relatively scarce, and medical institutions may face insufficient funds in the updating of traditional Chinese medicine equipment and talent training. Patients may also find it difficult to afford some high-cost traditional Chinese medicine treatment projects due to economic reasons. Facilitating factors refer to the factors that promote the implementation of the prevention and treatment technology in the current medical scenario, including the support system of medical institutions, the training and development of professionals, and the education level of patients.

[0047] In an embodiment of the present scheme, for each control technology in the appropriate control technology group, the knowledge, background and promoting factors of the current control technology are obtained and weighted summed to obtain the implementation effect of the current control technology.

[0048] The details are as follows: i , the implementation effect of each technology E implement (T i ) can be expressed as: E implement (T i )=f(K i ,C i ,F i ), where f is a comprehensive function that reflects the impact of knowledge, background and facilitating factors on implementation effects. The specific form can be: E implement (T i )=α·K i +β·C i +γ·Fi , where K i : Knowledge; C i : Background; F i : Promoting factors, where α, β, and γ are parameters that reflect the relative importance of each factor in the implementation process. Their respective weights are determined through expert discussion, and α+β+γ=1.

[0049] As mentioned above, different medical scenarios have different prevention and treatment strategies. This solution can use the implementation evaluation module to evaluate the implementation effect of prevention and treatment technologies in the current medical scenario.

[0050] After the implementation evaluation module evaluates the implementation effect of the prevention and control technology, the prevention and control program optimization module is used to optimize the prevention and control program based on the implementation effect of the prevention and control technology, where the prevention and control program consists of prevention and control technologies with good implementation effects.

[0051] In addition, if Figure 2 As shown, in order to further optimize the evaluation scheme, the prevention and treatment scheme optimization system for chronic diseases in the field of traditional Chinese medicine provided by this scheme further includes:

[0052] The feedback evaluation module is used to obtain the patient's feedback data during the implementation of the prevention and treatment plan, and to weight the feedback data at different time points to obtain feedback evaluation;

[0053] Furthermore, the implementation evaluation module adjusts the implementation effect of the prevention and control technology based on the feedback evaluation.

[0054] Specifically, when patients implement prevention and treatment plans for chronic diseases, feedback data at different time points are collected, and a weighting function is used to weight the feedback data at different time points to obtain a feedback evaluation. The feedback evaluation is used to evaluate the feedback effect of the patient when the prevention and treatment plan is dynamically implemented, and the prevention and treatment plan can be dynamically optimized in real time based on the feedback effect.

[0055] In some embodiments, feedback data refers to data generated by the patient during the process of implementing the prevention and treatment plan to provide feedback on the effectiveness of the current prevention and treatment plan, including patient health data and doctor feedback.

[0056] Specifically, the feedback data during the implementation of the prevention and control plan is defined as D = {d1, d2, ..., d m}, where d i Represents the feedback data at a certain point in time, and obtains the feedback evaluation through a weighted function: S feedback (d i )=w1·d i1 +w2·d i2 +…+w m ·d im , where d ij is the jth dimension of the feedback data, w jis the priority weight of the corresponding dimension, and the respective weights are determined through expert discussion, and

[0057] Correspondingly, the implementation assessment module weights the feedback assessment and the original implementation effect to adjust the implementation effect of the prevention and control technology. The specific calculation method is as follows:

[0058]

[0059] Where E adjusted (T i ) is the implementation effect after adjustment, S feedback (d i ) is the feedback evaluation, E implement (T i ) is the original implementation effect, and δ is the weighted coefficient of feedback evaluation.

[0060] It should be noted that the weighting coefficient of feedback evaluation defaults to 0.5, and the weighting coefficient is proportional to the number of years of implementation of the feedback evaluation. That is to say, the closer the feedback evaluation is to the present moment, the greater the weighting coefficient is.

[0061] In addition, in order to maximize the effectiveness of the evaluation plan, this plan comprehensively optimizes the implementation paths of multiple prevention and treatment technologies. That is to say, the prevention and treatment plan optimization module of this plan optimizes the evaluation plan based on the implementation effects of multiple prevention and treatment technologies, the resource constraints of the prevention and treatment technologies, and the needs of patients.

[0062] Specifically, the prevention and control scheme optimization module constructs the following optimization model:

[0063]

[0064] where w i is the priority weight of each evaluated technology, reflecting the importance of the technology in treating a specific chronic disease.

[0065] The optimization goal of this optimization model is to maximize the total treatment effect while satisfying resource constraints and patient needs, which can be expressed as follows:

[0066]

[0067] Among them, r i It is technology i Resource consumption, R max is the maximum total amount of resources; p i It is technology i The number of patients covered, D min is the minimum coverage requirement.

[0068] The control scheme optimization module of this program can ultimately consider various influencing factors in technology screening, background analysis, implementation optimization and multi-dimensional decision support, and finally obtain the optimal control scheme, that is, obtain the control technology combination with the maximum coverage within the limited resource consumption among the listed appropriate control technology groups.

[0069] Embodiment 2

[0070] Based on the same content of the first embodiment, Figure 3 As shown, this embodiment provides a method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine, including:

[0071] Based on clinical effect indicators, economic indicators and patient experience indicators, the appropriate prevention and treatment technology group is screened, where the appropriate prevention and treatment technology group includes at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine;

[0072] Build the i-PARIHS framework based on the knowledge, background and facilitating factors of the current medical scenario, and obtain the implementation effect of the prevention and control technologies in the appropriate prevention and control technology group in the i-PARIHS framework;

[0073] Optimize prevention and control plans based on the implementation effects of prevention and control technologies.

[0074] like Figure 4 As shown, in some embodiments, the method for optimizing the prevention and treatment plan for chronic diseases in the field of traditional Chinese medicine includes the steps of obtaining feedback data from patients during the implementation of the prevention and treatment plan, weighting the feedback data at different time points to obtain feedback evaluation, and adjusting the implementation effect of the prevention and treatment technology based on the feedback evaluation.

[0075] The contents that are the same as those in the first embodiment will not be described in detail here.

[0076] Those skilled in the art should understand that the technical features of the above embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0077] The above embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the present application. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the present application shall be subject to the attached claims.

Claims

1. A system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine, characterized in that: include: HTA evaluation module, used to screen appropriate prevention and treatment technology groups based on clinical effect indicators, economic indicators and patient experience indicators, where the appropriate prevention and treatment technology group includes at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine; The implementation evaluation module is used to build the i-PARIHS framework based on the knowledge, background and facilitating factors of the current medical scenario, and obtain the implementation effect of the prevention and control technologies in the appropriate prevention and control technology group in the i-PARIHS framework; The control scheme optimization module is used to optimize the control scheme based on the implementation effect of the control technology.

2. The system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 1, characterized in that: include: The feedback evaluation module is used to obtain the patient's feedback data during the implementation of the prevention and treatment plan, and to weight the feedback data at different time points to obtain feedback evaluation; And the implementation evaluation module adjusts the implementation effect of the prevention and control technology based on the feedback evaluation.

3. The system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 2, characterized in that: Feedback data at different time points are collected, and a weighting function is used to weight the feedback data at different time points to obtain a feedback evaluation, which is used to evaluate the feedback effect of patients when dynamically implementing the prevention and treatment plan.

4. The system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 2, characterized in that: The implementation assessment module weights the feedback assessment and the original implementation effect to adjust the implementation effect of the prevention and control technology.

5. The system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 1, characterized in that: Clinical effect indicators refer to indicators that reflect the therapeutic effects of current prevention and treatment technologies, economic indicators refer to indicators that reflect the cost-effectiveness of current prevention and treatment technologies, and patient experience indicators refer to indicators that reflect the patient experience of current prevention and treatment technologies.

6. The system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 1, characterized in that: For each prevention and treatment technology of chronic diseases in the field of traditional Chinese medicine, the clinical effect indicators, economic indicators, and patient experience indicators of the current prevention and treatment technology are obtained and the weighted sum is used to obtain the comprehensive evaluation score of the current prevention and treatment technology. The prevention and treatment technologies with comprehensive evaluation scores greater than the set threshold are screened to form an appropriate prevention and treatment technology group.

7. The system for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 1, characterized in that: Knowledge refers to the feasibility of implementing the prevention and treatment technology in the current medical scenario, background refers to the environmental factors for implementing the prevention and treatment technology in the current medical scenario, and promoting factors refer to the factors that promote the implementation of the prevention and treatment technology in the current medical scenario.

8. A method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine, characterized in that: include: Based on clinical effect indicators, economic indicators and patient experience indicators, the appropriate prevention and treatment technology group is screened, where the appropriate prevention and treatment technology group includes at least one prevention and treatment technology for chronic diseases in the field of traditional Chinese medicine; Build the i-PARIHS framework based on the knowledge, background and facilitating factors of the current medical scenario, and obtain the implementation effect of the prevention and control technologies in the appropriate prevention and control technology group in the i-PARIHS framework; Optimize prevention and control plans based on the implementation effects of prevention and control technologies.

9. The method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 8, characterized in that: include: Obtain feedback data from patients during the implementation of the prevention and treatment plan, weight the feedback data at different time points to obtain feedback evaluation, and adjust the implementation effect of the prevention and treatment technology based on the feedback evaluation.

10. The method for optimizing the prevention and treatment of chronic diseases in the field of traditional Chinese medicine according to claim 9, characterized in that: Weighted feedback evaluation and original implementation results are used to adjust the implementation effect of prevention and control technology.

Images